Immunogold TEM of otoconin 90 and otolin - relevance to mineralization of otoconia, and pathogenesis of benign positional vertigo

Hearing Research

Volumn 292, Issue 1-2, 2012, Pages 14-25

  Andrade, Leonardo R ^a,b   Lins, Ulysses ^b   Farina, Marcos ^b   Kachar, Bechara ^a   Thalmann, Ruediger ^c  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; OTOCONIN 90 PROTEIN; OTOLIN PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BENIGN PAROXYSMAL POSITIONAL VERTIGO; CONTROLLED STUDY; ELECTRON ENERGY LOSS SPECTROSCOPY; IMMUNOGOLD ELECTRON MICROSCOPY; IN VITRO STUDY; MINERALIZATION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OTOLITH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; EXTRACELLULAR MATRIX PROTEINS; GUINEA PIGS; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; OTOLITHIC MEMBRANE; VERTIGO;

EID: 84864813311     PISSN: 03785955     EISSN: 18785891     Source Type: Journal    
DOI: 10.1016/j.heares.2012.07.003     Document Type: Article

References (32)

1. Agrawal Y., Carey J.P., la Santina C.C., Schubert M.C., Minor L.B. Disorders of balance and vestibular function in US adults: data from the National Health and Nutrition Examination Survey, 2001-2004. Archives of Internal Medicine 2009, 169:938-944.
2. Anniko M., Ylikoski J., Wroblewski R. Microprobe analysis of human otoconia. Acta Otolaryngology 1984, 97:283-289.
3. Baloh R.W., Honrubia V., Jacobson K. Benign positional vertigo: clinical and oculographic features in 240 cases. Neurology 1987, 37:371-378.
4. Campos A., Canizares F.J., Sanchez-Quevedo M.C., Romero P.J. Otoconial degeneration in the aged utricle and saccule. Advances in Otorhinolaryngology 1990, 45:143-153.
5. Colfen H. Biomineralization: a crystal-clear view. Nature Materials 2010, 9:960-961.
6. Deans M.R., Peterson J.M., Wong G.W. Mammalian Otolin: a multimeric glycoprotein specific to the inner ear that interacts with otoconial matrix protein Otoconin-90 and Cerebellin-1. PLoS One 2010, 5:e12765.
7. Epley J.M. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo. Otolaryngology - Head and Neck Surgery 1992, 107:399-404.
8. Erway L.C., Purichia N.A., Netzler E.R., D'Amore M.A., Esses D., Levine M. Genes, manganese, and zinc in formation of otoconia: labeling, recovery, and maternal effects. Scanning Electron Microscopy 1986, 1681-1694.
9. Giachelli C.M. Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthodontics and Craniofacial Research 2005, 8:229-231.
10. Harada Y., Sugimoto Y. Metabolic disorder of otoconia after streptomycin intoxication. Acta Otolaryngologica 1977, 84:65-71.
11. Hunter G.K., Kyle C.L., Goldberg H.A. Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochemical Journal 1994, 300(Pt 3):723-728.
12. Jeong S.H., Choi S.H., Kim J.Y., Koo J.W., Kim H.J., Kim J.S. Osteopenia and osteoporosis in idiopathic benign positional vertigo. Neurology 2009, 72:1069-1076.
13. Kwan A.P.L., Cummings C.E., Chapman J.A., Grant M.E. Macromolecular organization of chicken type X collagen in vitro. Journal of Cell Biology 1991, 114:597-604.
14. Lim D.J. Otoconia in health and disease: a review. The Annals of Otology, Rhinology & Laryngology, Supplement 1983, 112:12-24.
15. Lins U., Farina M., Kurc M., Riordan G., Thalmann R., Thalmann I., Kachar B. The otoconia of the guinea pig utricle: internal structure, surface exposure, and interactions with the filament matrix. Journal of Structural Biology 2000, 131:67-78.
16. Lu W., Zhou D., Freeman J.J., Thalmann I., Ornitz D.M., Thalmann R. In vitro effects of recombinant otoconin 90 upon calcite crystal growth. Significance of tertiary structure. Hearing Research 2010, 268:172-183.
17. Mann S., Parker S.B., Ross M.D., Skarnulis A.J., Williams R.J. The ultrastructure of the calcium carbonate balance organs of the inner ear: an ultra-high resolution electron microscopy study. Proceedings of Royal Society of London Series B, Biological Sciences 1983, 218:415-424.
18. Murayama E., Herbomel P., Kawakami A., Takeda H., Nagasawa H. Otolith matrix proteins OMP-1 and Otolin-1 are necessary for normal otolith growth and their correct anchoring onto the sensory maculae. Mechanisms of Development 2005, 122:791-803.
19. Murayama E., Takagi Y., Ohira T., Davis J.G., Greene M.I., Nagasawa H. Fish otolith contains a unique structural protein, otolin-1. European Journal of Biochemistry 2002, 269:688-696.
20. Petralia R.S., Wenthold R.J. Immunocytochemistry of NMDA receptors. Methods in Molecular Biology 1999, 128:73-92.
21. Pote K.G., Hauer C.R., Michel H., Shabanowitz J., Hunt D.F., Kretsinger R.H. Otoconin-22, the major protein of aragonitic frog otoconia, is a homolog of phospholipase A2. Biochemistry 1993, 32:5017-5024.
22. Ross M.D., Peacor D., Johnsson L.G., Allard L.F. Observations on normal and degenerating human otoconia. The Annals of Otology, Rhinology & Laryngology 1976, 85:310-326.
23. Salamat M.S., Ross M.D., Peacor D.R. Otoconial formation in the fetal rat. The Annals of Otology, Rhinology & Laryngology 1980, 89:229-238.
24. Thalmann I., Hughes I., Tong B.D., Ornitz D.M., Thalmann R. Microscale analysis of proteins in inner ear tissues and fluids with emphasis on endolymphatic sac, otoconia, and organ of Corti. Electrophoresis 2006, 27:1598-1608.
25. Thalmann R., Ignatova E., Kachar B., Ornitz D.M., Thalmann I. Development and maintenance of otoconia: biochemical considerations. Annals of the New York Academy of Sciences 2001, 942:162-178.
26. Thalmann R., Thalmann I., Lu W. Significance of tertiary conformation of otoconial matrix proteins - clinical implications. Acta Otolaryngologica 2011, 131:382-390.
27. Verpy E., Leibovici M., Petit C. Characterization of otoconin-95, the major protein of murine otoconia, provides insights into the formation of these inner ear biominerals. Proceedings of the Natural Academy of Sciences USA 1999, 96:529-534.
28. Vibert D., Kompis M., Hausler R. Benign paroxysmal positional vertigo in older women may be related to osteoporosis and osteopenia. The Annals of Otology, Rhinology & Laryngology 2003, 112:885-889.
29. Wang Y., Kowalski P.E., Thalmann I., Ornitz D.M., Mager D.L., Thalmann R. Otoconin-90, the mammalian otoconial matrix protein, contains two domains of homology to secretory phospholipase A2. Proceedings of the Natural Academy of Sciences USA 1998, 95:15,345-15,350.
30. Welgampola M.S., Bradshaw A., Halmagyi G.M. Practical neurology-4: dizziness on head movement. Medical Journal of Australia 2011, 195:518-522.
31. Yang H., Zhao X., Xu Y., Wang L., He Q., Lundberg Y.W. Matrix recruitment and calcium sequestration for spatial specific otoconia development. PLoS One 2011, 6:e20498.
32. Zhao X., Yang H., Yamoah E.N., Lundberg Y.W. Gene targeting reveals the role of Oc90 as the essential organizer of the otoconial organic matrix. Developmental Biology 2007, 304:508-524.